| Bioactivity | Genevant CL1 is a lipid that can be used for mRNA lipid nanoparticle (LNP) vaccine delivery[1]. | ||||||||||||
| Name | Genevant CL1 | ||||||||||||
| CAS | 1450888-71-7 | ||||||||||||
| Formula | C39H73NO2 | ||||||||||||
| Molar Mass | 588.00 | ||||||||||||
| Appearance | Liquid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Michael D Buschmann, et al. Nanomaterial Delivery Systems for mRNA Vaccines. Vaccines (Basel). 2021 Jan 19;9(1):65. |